6/7/2023 10:29 AM
FibroGen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing results from a late-stage trial of pamrevlumab, its experimental drug to treat patients with Duche...
7/16/2021 12:16 PM
Stocks reversed earlier gains brought on by strong retail sales data and mixed earnings reports, as worse-than-expected inflation findings weighed on Wall Street. The U.S. consumer sentiment index ...
8/8/2017 10:47 AM
The Dow Jones Industrial Average (DJIA) got off to a slow start this morning, but has since edged just high enough to extend its lengthy record-setting streak. Drug company Valeant Pharmaceuticals In...